ACCURASEE
LIVE

Serial Number

90843692

Owner

Athenex, Inc.

Attorney

Christopher M. Thomas

First Use Date

Feb 21, 2017

Filing Date

Jul 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ACCURASEE Trademark

Serial Number: 90843692 • Registration: 7095938

ACCURASEE is a trademark filed by Athenex, Inc. on July 22, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Athenex, Inc. (23 trademarks)

Conventus Building
Buffalo, NY 14203

Entity Type: 03

Trademark Details

Filing Date

July 22, 2021

Registration Date

July 4, 2023

First Use Anywhere

February 21, 2017

First Use in Commerce

February 21, 2017

Published for Opposition

April 18, 2023

Goods & Services

Printed paper labels to reduce user error and assist with the correct selection of medication and medical products, sold as an integral component of bags sold filled with intravenous fluids used for the delivery of pharmaceutical preparations; printed paper labels to reduce user error and assist with the correct selection of medication and medical products, sold as an integral component of packaged pharmaceutical preparations in the nature of anticholinergics, anticholinesterases, anti-hypotensives, anesthetics, antibiotics, antiemetics, and sedatives; printed paper labels to reduce user error and assist with the correct selection of medication and medical products, sold as an integral component of packaged pharmaceutical preparations, intravenous bags filled with pharmaceuticals, syringes filled with pharmaceuticals, and vials filled with pharmaceuticals, with all of the aforementioned containing oncologic products and ancillary products, chemotherapy agents, anti-emitics, anti-infectives, anticholinergics, anticholinesterases, anti-hypotensives, biologicals, anesthetics for surgical and non-surgical use, antibiotics, and sedatives; printed paper labels to reduce user error and assist with the correct selection of medication and medical products, sold as an integral component of packaged biological preparations for the treatment of viral, infectious, metabolic, endocrine, musculoskeletal, joint, cardiovascular, cardiopulmonary, oncological, neurological, gastrointestinal, hormonal, psychiatric and immune system related diseases and disorders and cancer

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 4, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 4, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 18, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 18, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 29, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 14, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 24, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 23, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 23, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 27, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 27, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 27, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 15, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 23, 2021 NWOS
NEW APPLICATION ENTERED
Jul 26, 2021 NWAP